Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

Journal of Clinical Investigation

Volumn 104, Issue 4, 1999, Pages 431-437

  Garred, Peter ^a   Pressler, Tacjana ^a   Madsen, Hans O ^a   Frederiksen, Birgitte ^a   Svejgaard, Arne ^a   Høiby, Niels ^a   Schwartz, Marianne ^a   Koch, Christian ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; MANNOSE BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL;

EID: 0032695668     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6861     Document Type: Article

References (47)

1. Riordin, J.R., et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1073.
2. Koch, C., and Høiby, N. 1993. Pathogenesis of cystic fibrosis. Lancet. 341:1065-1069.
3. Turner, M.W. 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today. 17:532-540.
4. Epstein, J., Eichbaum, Q., Sheriff, S., and Ezekowitz, R.A.B. 1996. The collectins in innate immunity. Curr. Opin. Immunol. 8:29-35.
5. Sastry, K., et al. 1989. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J. Exp. Med. 170:1175-1189.
6. Taylor, M.E., Brickell, P.M., Craig, R.K., and Summerfield, J.A. 1989. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem. J. 262:763-771.
7. Guo, N., Mogues, T., Weremowicz, S., Morton, C.C., and Sastry, K.N. 1998. The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10. Mamm. Genome. 9:246-249.
8. Matsushita, M., and Fujita, T. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med. 176:1497-1503.
9. Thiel, S., et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature, 386:506-510.
10. p, the human Clq/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity. 6:119-126.
11. Sumiya, M., et al. 1991. Molecular basis of opsonic defect in immunodeficient children. Lancet. 337:1569-1570.
12. Garred, P., Madsen, H.O., Hofmann, B., and Svejgaard, A. 1995. Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency. Lancet. 346:941-943.
13. Summerfield, J.A., Sumiya, M., Levin, M., and Turner, M.W. 1997. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ. 314:1229-1232.
14. Summerfield, J.A., et al. 1995. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. 345:886-889.
15. Garred, P., et al. 1997. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet. 349:236-240.
16. Davies, E.J., et al. 1995. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 38:110-114.
17. Sullivan, K.E., Wooten, C., Goldman, D., and Petri, M. 1996. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 39:2046-2051.
18. Davies, E.J., et al. 1997. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J. Rheumatol. 24:485-488.
19. Graudal, N., et al. 1998. Mannan-binding lectin in rheumatoid arthritis. A longitudinal study. J. Rheumatol. 25:629-635.
20. Lipscombe, R.J., et al. 1992. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum. Mol. Genet. 1:709-715.
21. Madsen, H.O., et al. 1994. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics. 40:37-44.
22. Garred, P., Madsen, H.O., and Svejgaard, A. 1996. Genetics of human mannan-binding protein. In Collectins and innate immunity. R.A.B. Ezekowirz, K. Sastry, and K.B.M. Reid, editors. R.G. Landes. Austin, TX. 139-164.
23. Madsen, H.O., et al. 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155:3013-3020.
24. Madsen, H.O., Satz, M.L., Hogh, B., Svejgaard, A., and Garred, P. 1998. Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J. Immunol. 161:3169-3175.
25. Polgar, G.E., and Promadhat, V. 1971. Pulmonary function testing in children: techniques and standards. W.B. Saunders. Philadelphia, PA. 88 pp.
26. Høiby, N. 1977. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determination by means of crossed immunoelectrophoresis. A survey. Acta. Pathol. Microbiol. Scand. Suppl. 262:1-96.
27. Høiby, N. 1995. Microbiology of cystic fibrosis. In Cystic fibrosis. M.E. Hodson and D.M. Geddes, editors. Chapman and Hall Medical. London, United Kingdom. 75-98.
28. Schwartz, M., Johansen, H.K., Koch, C., and Brandt, N.J. 1990. Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum. Genet. 85:427-428.
29. Johansen, H.K., Nir, M., Høiby, N., Koch, C., and Schwartz, M. 1991. Severity of cystic fibrosis in patients homozygous and heterozygous for AF508 mutation. Lancet. 337:631-634.
30. Garred, P., et al. 1992. Diallelic polymorphism may explain variations of blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur. J. Immunogenet. 19:403-412.
31. Warwick, W.J., Pogue, R.E., Gerber, H.U., and Nesbitt, C.J. 1975. Survival patterns in cystic fibrosis. J. Chronic Dis. 28:609-622.
32. Frederiksen, B., Lanng, S., Koch, C., and Høiby, N. 1996. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol. 21:153-158.
33. Smith, J.J., Travis, S.M., Greenberg, E.P., and Welsh, M.J. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:229-236.
34. Pier, G.B., Grout, M., and Zaidi, T.S. 1997. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA. 94:12088-12093.
35. Ezekowitz, R.A.B., Day, L.E., and Herman, G.A. 1988, A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J. Exp. Med. 167:1034-1046.
36. Garred, P., et al. 1993. Mannan-binding protein: levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin. Exp. Immunol. 94:99-104.
37. Reading, P.C., Morey, L.S., Crouch, E.C., and Anders, E.M. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection in mice. J. Virol. 71:8204-8212.
38. Goldstein, W., and Doring, G. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56.
39. Johansen, H.K., and Høiby, N. 1992. Seasonal onset of initial colonization and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax. 47:109-111.
40. Botto, M., et al. 1998. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
41. Malhotra, R., et al. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via mannose-binding protein. Nat. Med. 1:237-243.
42. Govan, J.R., Hughes, J.E., and Vandamme, P. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
43. Kölble, K., Lu, J., Mole, S.E., Kaluz, S., and Reid, K.B.M. 1993. Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-23 close to the surfactant protein A gene cluster. Genomics. 17:294-298.
44. Griese, M., Birrer, P., and Demirsoy, A. 1997. Pulmonary surfactant in cystic fibrosis. Eur. Respir. J. 10:1983-1988.
45. Postle, A.D., et al. 1999. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 20:90-98.
46. Foster, C.B., et al. 1998. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102:2146-2155.
47. Garred, P., Harboe, M., Oettinger, T., Koch, C., and Svejgaard, A. 1994. Dual role of mannan-binding protein in infections: another case of heterosis? Eur. J. Immunogenet. 21:125-131.